Skip to main content
Top
Published in: International Orthopaedics 3/2006

01-06-2006 | Original Paper

Serum interleukin-6 response to elective total hip replacement surgery

Authors: M. A. Minetto, G. Oprandi, L. Saba, S. Mussino, A. Aprato, A. Massè, A. Angeli, P. Gallinaro

Published in: International Orthopaedics | Issue 3/2006

Login to get access

Abstract

The focus of this work was to study the serum interleukin-6 (IL-6) response to total hip replacement. Twenty-one patients received an uncemented total hip prosthesis. Venous samples for IL-6 determination were drawn before and after surgery. The IL-6 response was significant, and a peculiar heterogeneity of response was apparent: the medians of peak levels (82.3 pg/ml) and of areas under the response curve (51.8 pg/ml) distinguished between IL-6 high responders (HR) and IL-6 low responders (LR; p<0.0001). No difference was found in the gender composition of these groups, whereas the HR patients were older than the LR patients (p<0.05). The amount of IL-6 increase was found to correlate with patient age, whereas its slope was found to correlate with the duration of the surgical procedure. Moreover, the HR group presented a higher degree of hyperthermia in the days after surgery compared with the LR patients, without evidence of differences in postoperative complications, time to mobilisation, or length of stay in hospital. The main finding of our study was the evidence of a remarkable variability between individuals in the IL-6 response to surgery. Future studies are needed to identify the factors involved in the regulation of the cytokine response to surgery.
Literature
1.
go back to reference Andres BM, Taub DD, Gurkan I, Wenz JF (2003) Postoperative fever after total knee arthroplasty: the role of cytokines. Clin Orthop 415:221–231PubMedCrossRef Andres BM, Taub DD, Gurkan I, Wenz JF (2003) Postoperative fever after total knee arthroplasty: the role of cytokines. Clin Orthop 415:221–231PubMedCrossRef
2.
go back to reference Arnetz BB (1985) Endocrine reactions during standardized surgical stress: the effects of age and methods of anaesthesia. Age Ageing 14:96–101PubMedCrossRef Arnetz BB (1985) Endocrine reactions during standardized surgical stress: the effects of age and methods of anaesthesia. Age Ageing 14:96–101PubMedCrossRef
3.
go back to reference Beale E, Zhu J, Belzberg H (2002) Changes in serum cortisol with age in critically ill patients. Gerontology 48:84–92CrossRefPubMed Beale E, Zhu J, Belzberg H (2002) Changes in serum cortisol with age in critically ill patients. Gerontology 48:84–92CrossRefPubMed
4.
go back to reference Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMed
5.
go back to reference Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 79:161–165 Cruickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A (1990) Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci (Lond) 79:161–165
6.
go back to reference Giannoudis PV, Hildebrand F, Pape HC (2004) Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 86:313–323CrossRefPubMed Giannoudis PV, Hildebrand F, Pape HC (2004) Inflammatory serum markers in patients with multiple trauma. Can they predict outcome? J Bone Joint Surg Br 86:313–323CrossRefPubMed
7.
go back to reference Hogevold HE, Kierulf P, Ovstebo R, Reikeras O (1992) Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. Eur J Surg 158:339–345PubMed Hogevold HE, Kierulf P, Ovstebo R, Reikeras O (1992) Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. Eur J Surg 158:339–345PubMed
8.
go back to reference Kennedy JG, Rodgers WB, Zurakowski D, Sullivan R, Griffin D, Beardsley W, Sheehan L (1997) Pyrexia after total knee replacement. A cause for concern? Am J Orthop 26:549–552PubMed Kennedy JG, Rodgers WB, Zurakowski D, Sullivan R, Griffin D, Beardsley W, Sheehan L (1997) Pyrexia after total knee replacement. A cause for concern? Am J Orthop 26:549–552PubMed
9.
go back to reference Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687–699CrossRefPubMed Krabbe KS, Pedersen M, Bruunsgaard H (2004) Inflammatory mediators in the elderly. Exp Gerontol 39:687–699CrossRefPubMed
10.
go back to reference Krohn CD, Reikeras O, Aasen AO (1999) The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg 165:101–109CrossRefPubMed Krohn CD, Reikeras O, Aasen AO (1999) The cytokines IL-1beta and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-alpha, IL-6 and IL-6 soluble receptor, TNF-alpha and TNF soluble receptor I, and IL10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg 165:101–109CrossRefPubMed
11.
go back to reference Krohn CD, Reikeras O, Mollnes TE, Aasen AO (1998) Complement activation and release of interleukin-6 and tumour necrosis factor-alpha in drained and systemic blood after major orthopaedic surgery. Eur J Surg 164:103–108CrossRefPubMed Krohn CD, Reikeras O, Mollnes TE, Aasen AO (1998) Complement activation and release of interleukin-6 and tumour necrosis factor-alpha in drained and systemic blood after major orthopaedic surgery. Eur J Surg 164:103–108CrossRefPubMed
12.
go back to reference Menger MD, Vollmar B (2004) Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 389:475–484CrossRefPubMed Menger MD, Vollmar B (2004) Surgical trauma: hyperinflammation versus immunosuppression? Langenbecks Arch Surg 389:475–484CrossRefPubMed
13.
go back to reference Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M (1994) Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 6:181–186CrossRefPubMed Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, Hisano S, Ogawa M (1994) Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 6:181–186CrossRefPubMed
15.
go back to reference Singer M, De Santis V, Vitale D, Jeffcoate W (2004) Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:545–548CrossRefPubMed Singer M, De Santis V, Vitale D, Jeffcoate W (2004) Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 364:545–548CrossRefPubMed
16.
go back to reference van Deuren M, Twickler TB, de Waal Malefyt MC, Van Beem H, van der Ven-Jongekrijg J, Verschueren CM, van der Meer JW (1998) Elective orthopedic surgery, a model for the study of cytokine activation and regulation. Cytokine 10:897–903CrossRefPubMed van Deuren M, Twickler TB, de Waal Malefyt MC, Van Beem H, van der Ven-Jongekrijg J, Verschueren CM, van der Meer JW (1998) Elective orthopedic surgery, a model for the study of cytokine activation and regulation. Cytokine 10:897–903CrossRefPubMed
17.
go back to reference Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603–2607CrossRefPubMed Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603–2607CrossRefPubMed
18.
go back to reference Wilson KW, Wilson MR, McGlasson DL (1993) Serum endotoxin, tumor necrosis factor, and interleukin-6 response to total hip arthroplasty. Mil Med 158:712–716PubMed Wilson KW, Wilson MR, McGlasson DL (1993) Serum endotoxin, tumor necrosis factor, and interleukin-6 response to total hip arthroplasty. Mil Med 158:712–716PubMed
19.
go back to reference Wirtz DC, Heller KD, Miltner O, Zilkens KW, Wolff JM (2000) Interleukin-6: a potential inflammatory marker after total joint replacement. Int Orthop 24:194–196CrossRefPubMed Wirtz DC, Heller KD, Miltner O, Zilkens KW, Wolff JM (2000) Interleukin-6: a potential inflammatory marker after total joint replacement. Int Orthop 24:194–196CrossRefPubMed
Metadata
Title
Serum interleukin-6 response to elective total hip replacement surgery
Authors
M. A. Minetto
G. Oprandi
L. Saba
S. Mussino
A. Aprato
A. Massè
A. Angeli
P. Gallinaro
Publication date
01-06-2006
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 3/2006
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-006-0073-3

Other articles of this Issue 3/2006

International Orthopaedics 3/2006 Go to the issue

Letter to the Editor

Comment to Pecina et al.